PL404498A1 - Test diagnostyczny zakażeń Streptococcus agalactiae - Google Patents

Test diagnostyczny zakażeń Streptococcus agalactiae

Info

Publication number
PL404498A1
PL404498A1 PL404498A PL40449813A PL404498A1 PL 404498 A1 PL404498 A1 PL 404498A1 PL 404498 A PL404498 A PL 404498A PL 40449813 A PL40449813 A PL 40449813A PL 404498 A1 PL404498 A1 PL 404498A1
Authority
PL
Poland
Prior art keywords
streptococcus agalactiae
diagnostic test
streptococcus
agalactiae infections
infections
Prior art date
Application number
PL404498A
Other languages
English (en)
Other versions
PL231394B1 (pl
Inventor
Monika Brzychczy-Włoch
Sabina Górska
Ewa Brzozowska
Andrzej Gamian
Piotr B. Heczko
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL404498A priority Critical patent/PL231394B1/pl
Priority to EP14722388.7A priority patent/EP3014276B1/en
Priority to PCT/PL2014/050018 priority patent/WO2014209142A1/en
Priority to ES14722388.7T priority patent/ES2685833T3/es
Priority to PL14722388T priority patent/PL3014276T3/pl
Priority to US14/900,620 priority patent/US10048263B2/en
Publication of PL404498A1 publication Critical patent/PL404498A1/pl
Publication of PL231394B1 publication Critical patent/PL231394B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem zgłoszenia jest białko o określonej sekwencji aminokwasowej, wyizolowane ze szczepu Streptococcus agalactiae oraz sposób umożliwiający potwierdzenie zakażeń wywołanych przez gatunek bakterii Streptococcus agcdactiae. W sposobie wykorzystuje się specyficzną reakcję białek immunoreaktywnych otrzymanych z izolatów klinicznych Streptococcus agalactiae z przeciwciałami obecnymi w surowicy pacjentek.
PL404498A 2013-06-28 2013-06-28 Test diagnostyczny zakażeń Streptococcus agalactiae PL231394B1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL404498A PL231394B1 (pl) 2013-06-28 2013-06-28 Test diagnostyczny zakażeń Streptococcus agalactiae
EP14722388.7A EP3014276B1 (en) 2013-06-28 2014-03-28 A diagnostic test of streptococcus agalactiae infections
PCT/PL2014/050018 WO2014209142A1 (en) 2013-06-28 2014-03-28 A diagnostic test of streptococcus agalactiae infections
ES14722388.7T ES2685833T3 (es) 2013-06-28 2014-03-28 Una prueba diagnóstica de infecciones por Streptococcus agalactiae
PL14722388T PL3014276T3 (pl) 2013-06-28 2014-03-28 Test diagnostyczny zakażeń Streptococcus agalactiae
US14/900,620 US10048263B2 (en) 2013-06-28 2014-03-28 Diagnostic test of Streptococcus agalactiae infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL404498A PL231394B1 (pl) 2013-06-28 2013-06-28 Test diagnostyczny zakażeń Streptococcus agalactiae

Publications (2)

Publication Number Publication Date
PL404498A1 true PL404498A1 (pl) 2015-01-05
PL231394B1 PL231394B1 (pl) 2019-02-28

Family

ID=50680094

Family Applications (2)

Application Number Title Priority Date Filing Date
PL404498A PL231394B1 (pl) 2013-06-28 2013-06-28 Test diagnostyczny zakażeń Streptococcus agalactiae
PL14722388T PL3014276T3 (pl) 2013-06-28 2014-03-28 Test diagnostyczny zakażeń Streptococcus agalactiae

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14722388T PL3014276T3 (pl) 2013-06-28 2014-03-28 Test diagnostyczny zakażeń Streptococcus agalactiae

Country Status (5)

Country Link
US (1) US10048263B2 (pl)
EP (1) EP3014276B1 (pl)
ES (1) ES2685833T3 (pl)
PL (2) PL231394B1 (pl)
WO (1) WO2014209142A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3737948A1 (en) 2018-01-09 2020-11-18 Uniwersytet Jagiellonski Diagnostic test

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
US20040009574A1 (en) 2002-07-09 2004-01-15 Nanibhushan Dattagupta Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes
DK2054431T3 (da) 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
WO2009122388A1 (en) 2008-03-31 2009-10-08 National University Of Ireland, Galway A method for the detection of group b streptococcus (gbs) (streptococcus agalactiae) in mammals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3737948A1 (en) 2018-01-09 2020-11-18 Uniwersytet Jagiellonski Diagnostic test

Also Published As

Publication number Publication date
WO2014209142A1 (en) 2014-12-31
EP3014276A1 (en) 2016-05-04
PL231394B1 (pl) 2019-02-28
ES2685833T3 (es) 2018-10-11
US20160377613A1 (en) 2016-12-29
PL3014276T3 (pl) 2019-01-31
EP3014276B1 (en) 2018-06-06
US10048263B2 (en) 2018-08-14

Similar Documents

Publication Publication Date Title
CY1123518T1 (el) Ανθρωπινα αντισωματα enanti-tau
BR112016014284A2 (pt) anticorpo caninizado isolado ou um fragmento de ligação de antígeno do mesmo, ácido nucleico isolado, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos para aumentar a atividade de uma célula imune e para produzir um anticorpo caninizado ou fragmento de ligação de antígeno do mesmo
EA201490825A1 (ru) Tdp-43-специфически связывающие молекулы
WO2014204939A3 (en) Methods for quantitative determination of protein-nucleic acid interactions in complex mixtures
AR092818A1 (es) Anticuerpo tau humanizado
BR112012009854A2 (pt) proteína de ligação de antígeno il-23 humana
BR112016013347A2 (pt) anticorpo monoclonal humano neutralizante anti-il-33
TN2014000120A1 (en) Cd27l antigen binding proteins
WO2014037588A3 (en) Methods and compounds for preventing, treating and diagnosing an inflammatory condition
AU2018249796A1 (en) Antibody Fc variants for improving blood half-life
EA201790438A1 (ru) Антигенсвязывающие белки, которые связываются с cxcr5
MX2016005686A (es) Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX2015000686A (es) Metodo para detectar cancer.
BR112016010336A2 (pt) Anticorpo anti-humano-her3 alostérico não competitivo com neuregulina, fragmento de anticorpo, sequência de ácido nucleico, vetor, célula hospedeira, composição farmacêutica e método para tratamento de câncer
MX385451B (es) Proteínas sintéticas autoensamblables.
WO2019066617A3 (ko) 항 c-met 항체 및 이의 용도
PL401502A1 (pl) Epitop i jego zastosowanie
SG11201901435UA (en) Monoclonal antibody against melk and utilization thereof
UA86721U (ru) Способ ранней диагностики онкозаболеваний верхних дыхательных путей
AR121799A2 (es) Proteínas de unión a antígenos de il-23 humana
MX347154B (es) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
TH179718A (th) แอนติบอดีของมนุษย์ต่อเรสไพราทอรีซินไซเทียลไวรัส f โปรตีน และวิธีการใช้ของมัน
PL424214A1 (pl) Test diagnostyczny do wykrywania zakażeń i/lub nosicielstwa Streptococcus agalactiae wykorzystujący wyselekcjonowane markery polipeptydowe
BR112017007592A2 (pt) polipeptídeo, composição de polipeptídeos, métodos de produção de polipeptídeo e de detecção de anticorpos, uso de polipeptídeo e kit de reagentes